Showing results (41-50 of 53) with videos related to

Sort By:
Pageof 6
Hematological Oncology|February 3, 2025
Moderate-To-Severe Bone Marrow Fibrosis Is an Independent Risk Factor For Myelodysplastic Neoplasms Patients With Increased BlastsGaixiang Xu, Xingnong Ye, Yudi Zhang, et al.
Science Advances|April 17, 2024
RIPK3 deficiency blocks R-2-hydroxyglutarate-induced necroptosis in IDH-mutated AML cellsShuanghong Zhu, Yingwan Luo, Kongfei Li, et al.
American Journal of Cancer Research|January 8, 2021
Impact of mutational variant allele frequency on prognosis in myelodysplastic syndromesLingxu Jiang, Lu Wang, Chuying Shen, et al.
Breast Cancer Research : BCR|February 13, 2025
Clinical efficacy and therapy response prediction of neoadjuvant dalpiciclib plus letrozole in postmenopausal patients with HR+/HER2- stage II-III breast cancer (DARLING 01): a single-arm, open-label, exploratory studyLina Zhang, Yueping Liu, Chao Yang, et al.
Leukemia|July 25, 2024
The m6A methyltransferase METTL14 promotes cell proliferation via SETBP1-mediated activation of PI3K-AKT signaling pathway in myelodysplastic neoplasmsLingxu Jiang, Yudi Zhang, Jiejing Qian, et al.
Journal of Cancer Research and Clinical Oncology|January 11, 2022
Predictive values of mutational variant allele frequency in overall survival and leukemic progression of myelodysplastic syndromesLingxu Jiang, Li Ye, Liya Ma, et al.
Experimental Hematology & Oncology|January 29, 2025
EZH2 inhibition induces pyroptosis via RHA-mediated S100A9 overexpression in myelodysplastic syndromesQi Zhang, Yingwan Luo, Li Ye, et al.
Journal of Cancer Research and Clinical Oncology|January 22, 2017
Decitabine priming prior to low-dose chemotherapy improves patient outcomes in myelodysplastic syndromes-RAEB: a retrospective analysis vs. chemotherapy aloneLi Ye, Yanling Ren, Xinping Zhou, et al.
Haematologica|November 20, 2025
Decitabine plus all-trans retinoic acid versus decitabine monotherapy for myelodysplastic syndromes with excess blasts: a multicenter, randomized controlled trialXinping Zhou, Yanjuan Lin, Yan Gao, et al.
Haematologica|June 12, 2025
Recombinant human erythropoietin plus all-trans retinoic acid and testosterone undecanoate for the treatment of anemia in patients with lower-risk myelodysplastic syndromes: a multicenter, single-arm, prospective trialChen Mei, Gaixiang Xu, Cuiping Zheng, et al.
Pageof 6